Lumos Pharma | Cassa E Equivalenti



Cassa E Equivalenti Cambiamento Data
Agenus USD 3.46M 6.08M 2025-09
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Capricor Therapeutics USD 19.51M 3.73M 2025-09
Celldex Therapeutics USD 36.04M 12.99M 2025-09
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 7.46M 985K 2025-09
CSL USD 2.16B 633M 2025-06
Eli Lilly USD 7.27B 2.52B 2025-12
Grifols EUR 979.78M 334.84M 2024-12
Incyte USD 3.58B 650.78M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
Merck USD 18.17B 10.16B 2025-09
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Pfizer USD 1.34B 295M 2025-09
Prothena USD 330.84M 40.6M 2025-09
Sarepta Therapeutics USD 613.08M 102.48M 2025-09


Lumos Pharma Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.